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INTRODUCTION 
 
Urinary tract stone formation is multifactorial. Alteration in metabolism 
are found in 40%-60% of stone formers. Among them idiopathic 
hypercalciuria is the most frequent.  
 
Idiopathic hypercalciuria may be due to 
 An increase in intestinal calcium absorption 
 Enhanced demineralization of bones 
 
1,25 (OH)2 D3 regulates target tissue biological response through 
genomic events which involves steroid hormonal intra cellular Vitamin-D 
receptor. 
 
Researches has proven that increased calcium absorption is mediated by 
an increase in number of Vitamin-D receptors in intestine of genetic 
hypercalciuric rats. 
 
Very little is known about genetic factors that mediate susceptibility to 
calcium nephrolithiasis. A positive family  history is the most important risk 
factor when dietary factors are ruled out. The identification of genetic factors 
for calcium nephrolithiasis will lead to understanding of how the disease 
develops and assisting in evaluation of high risk individuals.  
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It is proven that in DNA sequence of human genome, many genes are 
polymorphic. In a specific gene there may be a single base pair substitution of 
one nucleotide (SNP) for another or valuable number of repeats of a short 
repetitive DNA sequence of a specific gene. Thereby 
 
 Gene transcription rate may change 
 There may be a change in the stability of messenger RNA 
 Activity and quality of resulting protein may vary 
 
Thus a number of disorders including nephrolithiasis is influenced by 
position of specific alleles in polymorphic genes.  
 
Calcitriol, the active metabolite of Vitamin-D has several major roles in 
the body.  
 It regulates the calcium and phosphate homeostasis 
 It regulates the synthesis of parathormone 
 Immune system and endocrine modulator  
 Plays against tumor development by its anti proliferative effect. 
 
Effect  of Vitamin-D  are mediated via nuclear Vitamin-D receptor. This 
receptor heterodimerises with retinoid X-receptor and changes gene 
transcription. So far in literature about 5 single nucleotide polymorphism of 
Vitamin-D receptor has been reported. 
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Several polymorphisms have been identified in VDR gene. The 
functional importance and effects on disease have been investigated  
 
The SNP sites most frequently reported have been  
 Start codon (Fok-I) 
 Intron 8 (Bsm-I) 
 Exon 9(Taq 1) 
 
In Western and Japanese population there is lack of data regarding 
allelic variations in VDR gene (Taq1). From stone formers in Indian 
subcontinent where ethnicity is quite different , there is only one such study  
published from North Indian population. To our knowledge no study has 
examined the relationship between Vitamin-D receptor gene (Taq1) 
polymorphism in South Indian population. Therefore the present study is an 
attempt to investigate it further using  a PCR based restriction analysis in 
unrelated stone forming individuals from our institution belonging to local 
ethnicity. 
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AIMS AND OBJECTIVES 
 
The aim of present study is to determine the role of Taq1 polymorphism 
of Vitamin-D receptor gene in calcium urolithiasis. 
 
Objectives 
1. To determine the risk attributed by Vitamin-D receptor polymorphism 
with specific reference to Taq1 genotype. 
2. To perform a stratified analysis of the genotype with clinical 
characteristics of patients like family history, recurrence, hypercalciuria 
in them. 
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REVIEW OF LITERATURE 
 
History of Urinary Stone Disease  
 Urinary stone disease has been causing concern for more than a million 
years. The oldest renal stone recorded was by Shattock in an Egyptian mummy 
in a tomb dating to approximately 4400 BC. Though  stone disease was 
investigated for over a thousand years, scientific research with clear cut 
investigations  determined the  stone composition only within the past 200 
years. 
 
 Hippocrates (460–370 BC), included a passage explaining the treatment 
of stones in  Hippocratic Oath:  
 
 “I will not cut persons laboring under the stone, but will leave this work 
to be done by men who are practitioners of this work.” 
 
Epidemiology of renal stones: 
 Urinary  tract stone disease affects about 10% of population in the 
industrialized part of the world. The annual incidence of kidney stones may go 
upto  0.6 to 2.0 % in developed  nations. In  a country like India  there are 
always wide regional variation. Southern part  of India has a relatively lower 
incidence when compared to compared to other parts.Maharashtra has a 
relatively higher incidence in India(about 7.6%). Equally high incidence has 
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been reported in Rajasthan and other western parts of  India. Various studies  
from  south India estimated the incidence to range between 5 – 7%. In our 
country 75% of urinary stone disease is due to calcium oxalate stones.  
 
Factors Affecting nephrolithiasis: 
 Urolithiasis is associated with many complicated factors. It can be 
triggered by various environmental influences, metabolic defects and genetic 
factors [1, 2]. The tendency of stone formation is mainly attributed to 
excessive calcium absorption, since calcium is the principal crystalline 
constituent in up to 80% of kidney stones [2]. 
 
Gender 
  Adult men are affected two to three times more commonly than adult 
women . But recent studies show that the difference between the sexes is 
narrowing quickly. Stamatelou and colleagues and reported such phenomenon 
in the recent dataset. 
 
Race/Ethnicity 
 Racial differences has a strong influence with stone disease. The 
difference in sex ranged from a male to female ratio of 2.3 in western world to 
0.65 in Africa while the same ratio is about 3.4 in Indian subcontinent(Soucie 
et al 1994). 
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Age: 
 Peaks during third to sixth  decade. World over there are too many 
variations in various literature. But females in menstrual age group have a 
protective role played by oestrogen which increases urinary citrate excretion 
and decreases calcium excretion in urine. (Heller  et al, 2002).   
 
Geography 
 Usually the incidence is high in tropical, hot and hilly regions like 
mountains and deserts where hot and arid ,dry climates prevail. 
 
Climate 
 Summer seasons see more stone cases due to two main reasons. One is 
due to dehydration following perspiration and the other factor is due to 
increase in production of Vitamin D due to excess sun exposure. 
 
Body Mass Index and Weight: 
 Increase in body mass has a direct correlation with increase in chance of 
stone formation. Hypocitraturia and hyperuricosuria are said to be the main 
reasons. 
 
Water 
 Incidence of stone disease is inversely related to fluid intake proven by 
several large observational studies. 
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Calcium Stones 
Hypercalciuria: 
 Among calcium stone formers the most common abnormality is 
idiopathic hypercalciuria. 
 
 Hypercalciuria is common  in 35% to 65% stone-forming of patients 
have identifiable hypercalciuria as an abnormality.  
 
 Various researches done in stone-forming rats having hypercalciuria has 
clearly suggested that  supersaturation of calcium phosphate and 
hypercalciuria are the major problems in stone formation. 
 
 Recently, it’s proven that the number of Randall plaques which are the 
potential precursors of the stone disease correlate with the urine calcium level 
and the number of stone episodes. 
 
 Daily amount of calcium filtered by the kidney is 260 mmol in which 
only 4 mmol is excreted out in urine, rest all are absorbed back by nephron. 
Increased urinary calcium forms complexes with chondroitin sulphate and 
citrate which are actually inhibitors of stone formation especially 
crystallisation. 
 
 Hypercalciuria is clearly defined by Parks et al that the urinary excretion 
of more than 4 mg/kg/day or more than 7 mmol/day. 
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 Traditionally, the term idiopathic hypercalciuria is a specific term used 
to denote stone formers whose actual metabolic abnormality was known. 
 
 There are three main sites where calcium homeostasis is actually 
regulated: bone, intestine, and kidney. Dysregulation at any of these sites can 
lead to hypercalciuria. Genetic hypercalciuric rat models have proven that 
hypercalciuria may be due to problem with multiple calcium transporting 
mechanisms. Classically Pak et al classified hypercalciuria into three types: 
Increased intestinal absorption produces absorptive hypercalciuria , Increased 
renal leak of calcium produces renal hypercalciuria, unwanted excess bone 
demineralisation produces resorptive hypercalciuria. 
 
Absorptive Hypercalciuria.  
 By definition Absorptive hypercalciuria  is  increased urinary calcium 
ion excretion after an oral  load of calcium. Sometimes even fasting 
hypercalciuria is seen in this scenario.  
 
 Here the pathology is increased calcium absorption from gut.This 
disease has two type where in type I urinary calcium levels remains high 
inspite of dietary calcium restrictions, Type 2 where calcium levels in urine is 
reduced with a calcium restricted diet. 
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 The calcium absorption from the gut suppresses PTH leading to increase 
calcium leak in urine.Since increased calcium absorption is matched by excess 
calcium loss in urine these patients have a normal calcium level inspite of 
increased absorption. 
 Although there is no clear cut mechanism to explain increase in calcium 
absorption from gut,the proposed mechanisms  shift the focus to an alteration 
in the vitamin d gene receptor in intestine. 
 Some others suggest that hyper sensitivity to Vitamin D by the receptor 
may be the cause. Hypercliuria has been investigated and linked to Vitamin D 
receptor by many genes.In study conducted by Jackman and colleagues(1999) 
Vitamin d gene polymorphism was linked to positive family history of stone 
disease. Also, The link between microsatellite marker and VDR gene focus on 
chromosome 12 q with calcium stone disease has been investigated by Scott 
and colleagues . 
 There are so many other studies too which fail to establish clear link 
between VDR gene focus and nephrolithiasis. Further researches showed a 
genetic locus for Absorptive hypercalciuria linked to chromosome 1q. 
 
 There are other metabolic abnormalities like the Hereditary 
Hypophosphataemic rickets in which excess phosphate waste in urine triggers 
vitamin D activity leading to increased calcium absorption from gut and 
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thereby excess calcium excretion in urine. This disease is inherited in an 
autosomal recessive pattern. R SLC34A1 and SLC34A3 are the responsible 
genes. NaPi-IIa and NaPi-IIc are the sodium phosphate transporters affected 
commonly in this disorder. But this disorder of Hypophosphataemic 
Hypercalciuric Rickets is an extremely rare disorder accounting for just 2% of 
patients. 
 
Renal Hypercalciuria.  
 98% of calcium filtered by glomerulus is absorbed back by the 
kidney.70 % absorbtion takes place in proximal convoluted tubule. Though 
there may be renal loss of calcium thus is compensated aptly by the combined 
action of two hormones PTH and Vitamin D which act together in maintaining 
in serum calcium levels. 
 
 So this disorder has a high level of urine calcium in spite of having 
normal serum calcium. This increased fasting urinary calcium and elevated 
PTH levels distinguish renal and absorptive hypercalciuria. 
 
 There are direct and indirect evidences to show the renal calcium leak. 
Sodium cellulose phosphate which is a calcium binding resin is not useful in 
them and urine calcium stays high inspite of taking it. Secondly there is an 
exaggerated response to hydrochlorthiazide diuretic ,since the problem is at the 
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renal tubular level.Calciuric response to oral glucose test is another test to 
predict renal hypercalciuria. 
 
 Various theories have been proposed to explain this issue. 
 Defect in chloride channel CIC-5 is ssen in diseases such as Dent 
disease and X linked hypophosphataemic rickets leading to hypercalciuria 
,nephrolithiasis,proteinuria. This transmembrane chloride channel deals with 
transmembrane voltage potential homeostasis. 
 
 Abnormality in chloride channel leads to hypercalciuria by activating 
Vitamin D indirectly.Anyhow, the exact mechanism is clearly not known. 
 
 Mutational changes in gene producing calcium sensing receptor usually 
leads to decreased serum calcium levels and excess calcium loss in urine not 
attended by action of PTH as the calcium sensing receptors are naive.This 
produces a state of salt losing nephropathy and ultimately leads to dysfunction 
of apical potassium channel ROMK. 
 
 Reported are  disorders of  sodium potassium chloride 
channel(Na+K+2Cl-) and individual potassium channel receptors(ROMK) 
which are reported to produce hypercalciuria. Basically these channel 
disorders are autosomal recessive disorders. 
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 An autosomal recessive disorder associated with such channels is given 
a special name called Bartter syndrome which produces hypercalciuria, 
hypokalemia and secondary hyperaldosteronism. 
 
Genetics factors attributing to calcium nephrolithiasis: 
 To understand the mechanism producing calcium stone formation and to 
know how the calciurics respond to drug, Genetic analysis is required. Mainly 
Single-candidate gene polymorphisms is looked as an researchable area in 
stone formers. In the era of having an idea of whole genome ,it may be 
possible to work out the risk of an individual to develop a stone ,how to treat 
them and advising them adequate diet which will prevent future stone disease. 
Twin and family studies has proven the importance of calcium nephrolithiasis. 
The relatives of stone forming patients always have a higher incidence stone 
formation when compared to non relatives.(1,3) Similarly monozygotic twins 
have a higher incidence when compared to dizygotic twins(5). 
 
A GENETIC APPROACH TO UROLITHIASIS: 
 Based on current family based disequilibrium studies, responsible genes 
were tested by means of case control or cohort analysis.  
 
 There may be tests that may look for single nucleotide polymorphism or 
a genetic marker pertaining to a particular trait is isolated and these tests are 
known as linkage dis equilibrium tests. So, an interested phenotype can be 
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mapped to a particular loci thereby mapping most of monogenic disorders on 
genes(6). 
 
 Case control study is often used to identify the allelic distribution of 
desired characters in a set of genetically comparable individuals. 
 
 So, always there is a possibility of falsely claiming a phenotypic 
character without a true association because of the phenomenon of genetic 
heterogenicity (7). 
 
 Apart from it, every gene also keeps interacting with other genes and 
environment which may influence the outcome of the disorder/phenotype 
(epistasis)(7,8).That is the reason why most of these assosiations reported from 
these studies cannot be repeated in another ethnic group.So, most of these 
studies require a huge sample population in order to stratify people according 
to phenotypic and genetic back ground. 
 
 Calcium salt precipitation or calcium metabolism altering genes 
producing calcium nephrolithiasis has been studied detaily. 1alpha-
hydroxylase of the 25(OH)-hydroxyvitamin D (VDD1), vitamin D receptor 
(VDR),Calcium sensing receptor(CASR), uromodulin (UMOD), osteocalcin 
(OCG), and osteopontin (OPN)  were all tested for linkage dis equilibirium for 
stone formation(8,9,10). VDR gene locus (12.q12-14)  was the only one 
among all these studies to show some direct association.  
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 Micro satellite markers were traditionally used in addition to restriction 
fragment length polymorphism in locating the exact foci of responsible culprit 
genes which produce calcium nephrolithiasis (9). These studies were positive 
for six of indian families whereas nine of European families didn’t show any 
association.(11.12). 
 
STUDIES ASSOCIATED WITH SINGLE-CANDIDATE GENES: 
 Of recent interests is various studies which link calcium nephrolithiasis 
and hypercalciuria to VDR gene  polymorphism sites worked up with specific 
Restriction fragment length polymorphisms  in either exon 9 site Taq I or 
intron 8 site enzyme like BsmI,Apa I, or starter codon  enzyme of  
FokI.(13,14) 
 
 Early onset, higher frequency of stones and decreased urinary citrate 
excretion were explained with allelic variations(13.15).Altogether the protein 
produced by VDR gene polymorphic variants is not going to be different but 
the actual change will be in mRNA stability of the product which is the actual 
proposed mechanism of alterations in urinary calcium excretion among various 
polymorphs (16). 
 
 The enzyme that mediates the absorption of citrate in the proximal 
tubular cells ie., phosphoenolpyruvate carboxykinase is altered by different 
polymorphic varieties of  VDR gene which may be the reason for 
 
 
16 
 
hypocitraturia that can produce calcium nephrolithiasis by an indirect means 
(17) 
 
SUMMARY OF FINDINGS IN GENETIC RESEARCHES IN 
NEPHROLITHIASIS: 
 Though the actual weightage and pathogenic impact on calcium 
nephrolithiasis by various genes like  VDR ,CLDN14, CASR and OPN  is not 
clearly known researches are on theirway  to pinpoint the location for type of 
insult producing human calcium nephrolithiasis. 
 
 Polymorphisms of  Vitamin D Receptor gene ,Calcium Sensing 
Receptor Gene and chloride channel gene(CLDN14) genes were implicated in 
producing calcium nephrolithiasis: 
 
 Calcium sensing receptor gene is usually associated with 
normocitraturic hypercalciuia calcium nephrolithiasis. 
 
 VDR gene polymorphisms is associated with hypocitraturia ,strong 
family history of calcium nephrolithiasis.  
 
VITAMIN D - GENERAL PHYSIOLOGY AND FUNCTION: 
 Normal bony development with adequate mineralization of a skeleton is 
based on action of the “Hormonal Vitamin” Vitamin D.The action of Vitamin 
D is carried on intestines and bone by means of Vitamin D receptor but , to 
 
 
17 
 
everybody’s  surprise this receptor is located not only in intestine and bone but 
every cell of our body. 
 
 Daily requirement of this vitamin is adequately obtained by sun 
exposure. Thus endogenously produced vitamin D will be sufficient for 
calcium homeostasis. In addition to it people who are deficient in this  can also 
receive an oral supplementation in the form of vitamin D3 (cholecalciferol) or 
D2 (ergocalciferol, derived from the irradiation of plant sterols). Cod liver oil 
is a very good source of Vitamin D and apart from it most of fish products.In 
European countries most of food stuffs like  milk, orange juice, and some 
cereals, breads, yogurts, and cheese are fortified with vitamin D. 
 
 The conversion of  7 dehydro cholesterol to previtamin D3 occurs 
secondary to ultraviolet B  light (wavelength 290-315 nm) exposure and this 
happens in epidermis and dermal layer. In  Body heat Vitamin D3 forms from 
previtamin D3 by means of isomerization.Vitamin D3 in turn binds to vitamin 
D-binding protein (VDBP) in serum. 
 
 In presence of 25 hydroxylase of liver Vitamin D3 is converted to 
25(OH) D3 .In human serum  25(OH) D3 is the major vitamin D metabolite 
and it’s known as the best indicator of individual Vitamin D status . 
 
 1-alpha hydroxylase present in kidneys convert 25(OH) D3 to 1,25-
dihydroxyvitamin D3 [calcitriol] by hydroxylating it. Calcitriol is  the most 
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biologically active form of Vit D 3. 1,25 dihydroxyvitamin D3 mainly has it’s 
action in the intestine, kidney, and bone to regulate calcium and phosphate 
metabolism. 
 
VITAMIN D RECEPTOR (VDR) 
 It’s a nuclear receptor belonging to steroid hormonal family. Also 
known as calcitriol receptor. Ultimately vitamin D acts through this nuclear 
receptor and produces new gene expression by mediating necessary protein 
synthesis. It is encoded on chromosome 12. 
 
 VDR contains 427 amino acids which has a ligand binding domain,two 
zinc fingers,a flexible hinge region, a DNA binding domain and an activation 
function domain.The hinge region has a Heat Shock Protein 70 site.The ligand 
binding domain has a C- terminal with a transcriptional activation function. 
 
Structure of Vitamin D receptor 
 Calcitriol enters the cell and binds to VDR, after which the complex is 
phosphorylated. This complex binds to retinoic acid or retinoid X receptor. 
Vitamin D response elements get attached to the zinc fingers on VDR. 
Approximately 60 genes are regulated by Vitamin D. That’s why even a small 
mRNA transcriptional change in the receptor usually brings major changes in 
so many genes produced. 
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Role of Vitamin D in regulation on gene expression 
 Intestinal calcium channels and calcium binding proteins are 
upregulated by the action of calcitriol. This favours calcium transport from 
lumen to circulation. Similar receptor are also found in osteoclasts of bone 
which help in absorbing calcium from boine in times of need to maintain the 
calcium homeostasis. 
 
There are specific signal pathways which have an influence on the 
positive and negative feedback mechanism to regulate the activity of 1,25-
dihydroxyvitamin D3 both in intestines and bones. Apart from intestine and 
bone, 25(OH)D-l-hydroxylase is also present in so many other tissues thereby 
favouring these tissues to produce their own active hormones at times of need. 
Eg. Prostate, colon, lung, breast. 
 
VITAMIN D RECEPTOR GENE 
The human VDR is exactly located at chromosome  12ql3-14. Studies 
on osteoporotic females turned the attention of the world towards this gene 
which led to further research on bone mineral density and calcium 
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homeostasis. The ligand binding region is coded by exons 4 to 9,while exon 2 
and 3 code for a DNA binding domain, whereas exons IA and IF cod ethe 
untranslated region in 5’ terminal and altogether there are 14 exons. 
 
SINGLE NUCLEOTIDE POLYMORPHISM (SNP) 
If there is  a difference between paired chromosomes or when there are 
variations in a single nucleotide among members of a same species  this DNA 
sequence variation is called  single nucleotide polymorphism. 
 
 To define an entity as a SNP it has to occur at least in 1% of population. 
SNP  usually predicts the risk of an individual to get particular disease like 
renal or heart disease, how they respond to medical treatment..The SNP pattern 
found in affected individuals is  compared with the SNP pattern of an 
unaffected individuals to determine the level of  association  of specific 
disease.  Disease susceptibility to one particular disease process for a particular 
SNP can be fairly judged if that SNP is common in affected population. 
 
VITAMIN D RECEPTOR GENE POLYMORPHISMS 
Most studies of Vitamin D receptor and calcium urolithiasis  have 
focused on five polymorphisms: 
1) rs 10735810 or Fokl polymorphism on exon 2 (F and f) 
2) rs 1544410 or BsmI on intron 8 (B and b) 
3) rs 731236 or TaqI on exon 9 (T and t) 
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4) rs 7975232 or Apal on intron 8 (A and a) 
5) poly(A) mononucleotide repeat at the 3-UTR section of the gene.  
(L and S) 
 
 
Schematic diagram of VDR gene demonstrating different restriction sites 
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The function of product genes mainly vary based on the location of 
genetic polymorphism. Therefore the start codon polymorphism may produce 
an effect totally different from the one located near ligand binding domain. 
 
When specific alleles tend to be linked together it’s known Linkage 
disequilibrium. There is also proven fact that poly A alleles in 3’ UTR region 
are in linkage disequilibrium with Bsm I, ApaI and Taq I. 
 
These genetic variations may not actually correlate well with change in 
Vitamin D Receptor but actually has it’s influence on VDR responsive gene 
expression. For example “t” allele of TaqI has higher activity when compared 
to “T” allele. Similarly “S” allele of Poly A polymorphism has similar higher 
activity when compared to “L: allele. 
 
Most studies of VDR and calcium urolithiasis have been conducted 
predominantly in non-Hispanic white populations. More studies are needed in 
other races. To our knowledge, no studies have examined the relationship 
between Vitamin D receptor gene polymorphisms and risk of urolithiasis in 
South Indian population. 
 
 It’s quite common to find allelic variations seen in VDR gene in various 
populations. Thymine/cytosine polymorphism in first two start codons   
Separated by  3 codons  is a known DNA sequence variant.                                                                                                                                                                                                                  
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 Restriction fragment Length Polymorphism is used to differentiate 
various alleles  in  Fok I ,Apa I ,Bsm I,and our gene of interest Taq I. 
 
TaqI Polymorphism in urolithiasis studies so far: 
 So far 9 studies have been reported in literature.When all of the 9 studies 
were pooled, no significant study heterogeneity was detected . Marginal 
positive association was found between the TaqI polymorphism and  
urolithiasis risk in  allelic comparisons, while the pooled analyses in the 
dominant model and recessive model were insignificant. But, sensitivity 
analysis after excluding all the studies with controls deviating from Hardy 
Weinburg  Equilibrium  indicated an increased urolithiasis risk associated with 
tt+Tt genotype in the dominant model (OR = 1.35, 95% CI). 
 
 Stratified analysis based on the regional characteristics suggested a 
similar significant association in the dominant genetic model in the Asian 
subgroup (OR = 1.41, 95% CI ) but the other subgroups yielded insignificant 
results. Moreover calcium stone-specific associations also yielded insignificant 
results. 
 
 There are various studies based on SNP sites like start codon FokI 
,Intron 8 BsmI polymorphism and calcium urolithiasis  in  European and Asian 
ethnicity. However, there are no reported studies till date which analyses the 
role of Taq I polymorphism and its association to calcium nephrolithiasis from 
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the ethnicity belonging to  South Indian population. PCR based restriction 
analysis  is used to  analyse VDR gene Taq I polymorphism and its role in 
stone formation, exclusively based on south Indian population. 
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MATERIALS  AND METHODS 
Subjects: 
  50 patients  being treated in Urology Department of Rajiv Gandhi 
Government General Hospital between age group 20 to 70 years with 
documented calcium stone disease  with a history of spontaneous stone 
passage or any kind of treatment for stone disease whose stone composition 
had calcium as major component  were included in the study. 
 
 Of these 50 patients, 25  had only one episode of calcium-stone disease 
and they were stratified as Group 1  and the remaining 25 patients  with 
recurrent calcium-stone disease constituted Group 2 . Fifty normal subjects  
with no history or radiological finding of stone disease composed the non-
stone former control group Group 3. 
 
Inclusion criteria ; 
 Calcium containing renal stone detected and treated where calcium 
being the major component of the calculus/calculi.  
 
Exclusion criteria: 
1. Any patients with the history of medications that affect urinary calcium 
excretion or excessive intake of vitamin D or excessive calcium intake 
were excluded. 
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2. Patients or controls with abnormal Vitamin D, Calcium or Phosphorous 
serum levels were also excluded from the study. 
3. Infection stones(struvite stones) or stones due to congenital enzymatic 
or metabolic abnormality were all excluded from the study. 
 
Family History: 
  A family history of  urolithiasis was sought from each patient. Family 
history was considered positive if any of sibling, a parent, grandparent or 
parental siblings had a history of renal-stone disease.  
 
 The study was performed with local Ethical Committee approval, and 
informed consent was obtained from all subjects. 
 
 Blood samples for measurement of  biochemical parameters were 
obtained in the fasting state at 8 AM. Serum calcium and phosphate were 
measured with the use of  AutoAnalyzer. Serum concentrations of  Vitamin D3  
was measured by radioimmunassay method (RIA).  
 
 Hypercalciuria is defined by a 24-h urinary calcium excretion more than 
4 mg/kg per day . The 24-h urinary calcium excretion results were available in 
all 100 subjects(Both cases and controls)  comparison between genotypes were 
carried out accordingly. 
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 Groups were compared in terms of age, gender distribution, presence of 
familial (first degree) stone disease history and the status of VDR Taq I gene 
polymorphism. 
 
GENOMIC DNA ISOLATION BY HIGH SALTING METHOD 
MATERIALS REQUIRED: 
 Red Cell lysis buffer (RCLB) 
(Tris HC1 - 10 mM, Magnesium Chloride - 10 mM,  
Potassium Chloride - 10 mM, EDTA - 2 mM) 
 Nucleated Cell lysis buffer (NCLB) 
(Tris HC1 - 10 mM, Magnesium Chloride - 10 mM, Potassium  
Chloride - lOmM, EDTA - 2 mM, Sodium Chloride – 400 mM)  
 Triton X 100 
 Sodium dodecyl sulphate - 10% 
 Sodium Chloride - 5M 
 Absolute Ethanol 
 70% Ethanol 
 Sterile water 
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PROCEDURE:  
RBC lysis 
The peripheral blood samples from the vacutainer (3-4 ml) containing 
EDTA was taken in labeled polypropylene tubes. Double the volume of Red 
cell lysis buffer (RCLB) and six drops of 0.1% commercially obtained Triton -
X 100 was added to the blood, mixed gently and incubated in a water bath at 
37°C for 5 minutes. 
 
Tubes were removed from the water bath and centrifuged at 2000rpm, 
4°C for 15 minutes. The supernatant was discarded carefully without 
disturbing the pellet. To the pellet, 10ml of RCLB was added and vortexed 
gently and centrifuged at 2000rpm, 4°C for 15 minutes. The supernatant was 
discarded carefully without disturbing the pellet. 
 
WBC lysis 
To the pellet, 1 ml of Nucleated cell lysis buffer (NCLB) and 20ul of 
10% SDS was added and vortexed._The tubes were incubated at 55°C for 1 
hour. At the end of 1 hour, the contents were transferred into a microfuge tube 
and 400 ul of 5M Sodium Chloride was added. The tubes were centrifuged at 
10000 rpm, 4°C for 15 minutes. 
 
  
 
 
29 
 
 
 
DNA precipitation 
The supernatant was transferred into a polypropylene tube and added 
double the volume of chilled absolute ethanol. The visible DNA strands were 
transferred into a labeled microfuge tube with a micropipette and 400 ul of 
70% ethanol was added. The tubes were centrifuged at 2000 rpm, 4°C for 5 
minutes. The supernatant was discarded and pellet was allowed to air dry. The 
pellet was dissolved in 100 - 150 ul of sterile nuclease free water and 
incubated at 4°C overnight for dissolving the DNA. 
 
AGAROSE GEL ELECTROPHORES 
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GEL DOCUMENTATION SYSTEM: 
 
DNA VISUALISED ON GEL 
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POLYMERASE CHAIN REACTION 
MATERIALS REQUIRED 
 Forward primer 
 Reverse primer 
 lOXTaq buffer 
 Taq polymerase enzyme (3U/ul) 
 Deoxyribonucleotides (dATP, dCTP, dGTP, dTTP) - 10 mM 
 DNA samples (control and patients' DNA samples) - 100 ng 
 Sterile water 
 
SEQUENCE OF THE PRIMERS 
The primer sequences for TaqI  polymorphisms: 
 5′-GGGACGATGAGGGATGGACAGAGC-3′ and 
 5′-GGAAAGGGGTTAGGTTGGACAGGA-3′.(51) 
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PCR REACTION MIXTURE: 
S. 
No 
COMPONENTS CONCENTRATION QUANTITY(ul) 
1. Sterile water  14.5 
2. 10X Taq buffer IX 2.0 
3. dNTPmix 0.2 mM 0.4 
4. Forward primer 50 pmoles 0.3 
5. Reverse primer 50 pmoles 0.3 
6. Taq Polymerase 1.5 units 0.5 
7. DNA samples 100 ng 2.0 
 
GRADIENT PCR FOR STANDARDIZATION OF ANNEALING 
TEMPERATURE 
The above components were added to 0.2 ml PCR vials and Gradient 
PCR was performed for a gradient of 55°C to 65°C to standardize the 
annealing temperature. 10 ul of the PCR products thus obtained were mixed 
with 2 ul of 6X gel loading dye and electrophoresed on a 2% agarose gel 
containing EtBr, (0.5 ug/ml) along side a lOObp marker (Bangalore Genei). 
The optimum annealing temperature for Apal and TaqI was 61°C and for BsmI 
was 63°C. 
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PCR CONDITIONS FOR VDR GENE: 
(EXON 9 TaqI) 
 
CONDITIONS TEMPERATURE TIME TEMPERATURE TIME 
Initial denaturation 94°C 5 mins 94UC 5 mins 
Denaturation 94°C 45 sees 94UC 45 sees 
Annealing 61UC 45 sees 63°C 30 sees 
Extension 72°C 1 min 72°C 1 min 
Final extension 72°C 5 mins 72°C 5 mins 
 
Total number of cycles = 30. Hold at 4 °C after 30tn cycle 
 
PURIFICATION OF PCR PRODUCT 
MATERIALS REQUIRED: 
PCR product    -  20 ul Absolute ethanol 
Nuclease free sterile water - 70% ethanol 
Sodium acetate (pH - 5.2)  - 3M  
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 PROCEDURE: 
The PCR product (20 ul) was transferred into a microfuge tube and 
triple the volume of nuclease free sterile water (60 jul) and one-tenth the 
volume of 3M Sodium Acetate (pH - 5.2) was added. To this mix, double the 
volume of Absolute ethanol was added and kept in freezer overnight for 
precipitation. Next day, the microfuge tubes were centrifuged, at 10000 rpm 
for half an hour at 4°C. 
 
Supernatant was discarded and 200 ul of 70% ethanol was added to 
microfuge tubes and centrifuged, at 10000 rpm for half an hour at 4°C. 
Supernatant was discarded immediately and the microfuge tubes were air-
dried. 10 ul of sterile nuclease free water was added to the microfuge tubes and 
the purified product was allowed to dissolve overnight in the refrigerator. 
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PCR  ANALYSIS 
 
 
RFLP  ANALYSIS OF TaqI  IN AGAROSE GEL: 
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RESTRICTION FRAGMENT LENGTH POLYMORPHISM 
REACTION MIXTURE: 
 
S.No COMPONENTS 
WORKING 
CONCENTRATION 
QUANTITY 
ADDED(uL) 
1. Purified PCR product  10.0 
2. Water  7.6 
3. Buffer (10X) IX 2.0 
4. BSA(IOOX) IX 0.2 
5. Enzyme (10 U/ul) 2 units 0.2 
Total volume = 20 ul 
 
RESTRICTION SITE OF ENZYMES 
TaqI    5' ... TACGA... 3'   3' ... AGCAT... 5'  
 
PROCEDURE: 
The reaction mixture was prepared to a total volume of 20 ul. The 
samples were kept for digestion at 65°C in a water bath for 2 hours. 10 ul of 
the digested product was mixed with 2 ul of 6X gel loading dye and 
electrophoresed on a 2% agarose gel containing EtBr (0.5 ug/ml), along side a 
l00bp marker (Bangalore Genei). 
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STATISTICAL ANALYSIS 
Statistical analysis was done using Statistical Package for the Social 
Sciences SPSS software. 
 
HARDY WEINBERG PRINCIPLE / EQUILIBRIUM / LAW 
The Hardy-Weinberg principle states that both allele and genotype 
frequencies in a population remain constant or are in equilibrium from 
generation to generation unless specific disturbing influences are introduced. 
These disturbing influences include non-random mating, mutations, selection, 
limited population size, random genetic drift and gene flow. 
 
In the simplest case of a single locus with two alleles: the dominant 
allele is denoted A and the recessive a and their frequencies are denoted by p 
and q; freq(A)=p; freq(a)=#; p + q = 1. If the population is in equilibrium, then 
we will have freq(AA)=p for the AA homozygotes in the population, 
freq(aa)=^2 for the aa homozygotes, and freq(Aa)=2p# for the heterozygotes. 
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RESULTS 
 
 
Calcium nephrolithiasis cases: 
 
               Among fifty stone disease patients who belonged to south indian 
population, 29 cases (53.7%) were males and 21 cases(45.7%) were females. 
The average age of cases was 41.68 with a standard deviation of 12.94, 
whereas the average age of the controls was 44.18 with a standard deviation of 
12.81.There was no statistical significance between the age values. 
 
Case distribution between sexes 
 
   Group Total P value 
    Control Cases   
Sex Male Count 25 29 54  
 
 
 
 
 
 
0.422 
    % within 
Sex 
46.3% 53.7% 100.0% 
    % within 
Group 
50.0% 58.0% 54.0% 
  Female Count 25 21 46 
    % within 
Sex 
54.3% 45.7% 100.0% 
    % within 
Group 
50.0% 42.0% 46.0% 
Total Count 50 50 100 
  % within 
Sex 
50.0% 50.0% 100.0% 
  % within 
Group 
100.0% 100.0% 100.0% 
  
 Though the number of male cases were more when compared to female 
cases ,this lot was chosen randomly from a huge pool of patients visiting 
Urology department, RGGGH and there was no statistically significant more 
number among the male group owing to the small sample size. 
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Mean age value of cases and controls 
 
         
 Group N Mean 
Std. 
Deviation 
P value 
Age in 
years 
Control 50 44.18 12.814 
0.334  
Cases 
50 41.68 12.940 
 
 
 
 
Sex
FemaleMale
C
o
u
n
t
30
28
26
24
22
20
Group
Control
Cases
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ANALYSIS OF 24 HR URINARY CALCIUM VALUES: 
 There were 26 stone formers with elevated 24 hr urinary calcium levels 
accounting to 52% of  stone disease patients.The reported incidence of 
hypercalciuria in Calcium nephrolithiasis is in the range of 33% to 52% 
according to various studies reported in literature. A point to be noted here is 
even 4 (8%)controls who never had any incidence or family history of stone 
disease also had hypercalciuria. 
 
24 hr urinary calcium in cases and controls 
 
   Group Total P value 
    Control Cases    
 
 
<0.001 
24 hr urinary 
calcium 
(mg/kg/day) 
Normocalciuria Count 
46 24 70 
    % within 24 hr 
urinary calcium 
(mg/kg/day) 
65.7% 34.3% 100.0% 
    % within Group 92.0% 48.0% 70.0% 
  Hypercalciuria Count 4 26 30  
 
 
 
 
<0.001 
    % within 24 hr 
urinary calcium 
(mg/kg/day) 
13.3% 86.7% 100.0% 
    % within Group 8.0% 52.0% 30.0% 
Total Count 50 50 100 
  % within 24 hr 
urinary calcium 
(mg/kg/day) 
50.0% 50.0% 100.0% 
  % within Group 100.0% 100.0% 100.0% 
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 Hypercalciuria was statistically more significant among cases when 
compared to controls. But an interesting finding as proven by previous similar 
studies to be noted here is that hypercalciuria is not universal in all calcium 
stone diseases.This exposes the lacuna in knowledge that there are other 
genetic or metabolic causes  which may play an additional role in calcium 
nephrolithiasis. This clearly explains the fact calcium nephrolithiasis is 
multifactorial and has so many other determinants to play a role. 
 
                              
 
 
24 hr urinary calcium (mg/kg/day)
HypercalciuriaNormocalciuria
C
o
u
n
t
50
40
30
20
10
0
Group
Control
Cases
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Distribution of Taq I genotype between groups 
 
   Group Total P value 
    Control Cases    
Taq 1 
genotype 
 
        TT 
Count 
31 15 46 
 
 
 
    0.001 
    % within 
Taq 1 
genotype 
67.4% 32.6% 100.0% 
    % within 
Group 
62.0% 30.0% 46.0% 
    
        Tt 
Count 
18 24 42 
 
 
 
 
  <0.001 
    % within 
Taq 1 
genotype 
42.9% 57.1% 100.0% 
    % within 
Group 
36.0% 48.0% 42.0% 
   
       tt 
Count 
1 11 12 
 
 
 
 
   <0.001 
    % within 
Taq 1 
genotype 
8.3% 91.7% 100.0% 
    % within 
Group 
2.0% 22.0% 12.0% 
Total Count 50 50 100  
  % within 
Taq 1 
genotype 
50.0% 50.0% 100.0% 
 
  % within 
Group 
100.0% 100.0% 100.0% 
 
 
 Among  the various polymorphic genotypes the presence of “t” allele 
strongly has a positive impact on stone formation.The number of  tt 
polymorphs with stone disease was 11(ie. 91.7% of  total tt population) .This 
clearly proves the statistically significant increased risk of stone formation in 
the presence of tt genotype.In the Tt allelic group 24 (57.1%) were stone 
formers having statistically significant increased chance of stone formation 
proving the role of “t” allele linked to stone disease .Whereas in TT allelic 
group most of them were controls ,31in number forming 62% of control limb . 
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Comparing 24 hr urinary calcium among various Taq 1 genotypes: 
                
                    Among 11 cases of tt polymorphs  9  had hypercalciuria(8 cases 
and one control)  forming 75% of the group. Hypercalciuria was statistically 
more significant in tt polymorphs. A similar observation was seen with Tt 
cases thereby re-emphasizing the role of “t” allele in hypercalciuria and  
nephrolithiasis.  
 
 
 
 
 
Taq 1 genotype
ttTtTT
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Comparing 24 hr urinary calcium among various Taq 1 genotypes: 
 
Taq 1 
genotypes     Group Total 
P 
value 
    Control Cases    
TT 24 hr urinary 
calcium 
(mg/kg/day) 
Normocalciuria Count 
31 9 40 
 
 
 
 
 
 
 
0.001 
      % within 24 hr 
urinary calcium 
(mg/kg/day) 
77.5% 22.5% 100.0% 
      % within Group 100.0% 60.0% 87.0% 
    Hypercalciuria Count 0 6 6 
      % within 24 hr 
urinary calcium 
(mg/kg/day) 
.0% 100.0% 100.0% 
      % within Group .0% 40.0% 13.0% 
  Total Count 31 15 46 
  % within 24 hr 
urinary calcium 
(mg/kg/day) 
67.4% 32.6% 100.0% 
  % within Group 100.0% 100.0% 100.0%  
 
 
 
 
 
 
0.027 
Tt 24 hr urinary 
calcium 
(mg/kg/day) 
Normocalciuria Count 
15 12 27 
      % within 24 hr 
urinary calcium 
(mg/kg/day) 
55.6% 44.4% 100.0% 
      % within Group 83.3% 50.0% 64.3% 
    Hypercalciuria Count 3 12 15 
      % within 24 hr 
urinary calcium 
(mg/kg/day) 
20.0% 80.0% 100.0% 
      % within Group 16.7% 50.0% 35.7% 
  Total Count 18 24 42 
  % within 24 hr 
urinary calcium 
(mg/kg/day) 
42.9% 57.1% 100.0% 
  % within Group 100.0% 100.0% 100.0% 
tt 24 hr urinary 
calcium 
(mg/kg/day) 
Normocalciuria Count 
0 3 3 
 
 
 
 
 
 
 
 
 
  
0.040 
 
 
 
 
 
      % within 24 hr 
urinary calcium 
(mg/kg/day) 
.0% 100.0% 100.0% 
      % within Group .0% 27.3% 25.0% 
    Hypercalciuria Count 1 8 9 
      % within 24 hr 
urinary calcium 
(mg/kg/day) 
11.1% 88.9% 100.0% 
      % within Group 100.0% 72.7% 75.0% 
  Total Count 1 11 12 
  % within 24 hr 
urinary calcium 
(mg/kg/day) 
8.3% 91.7% 100.0% 
  % within Group 100.0% 100.0% 100.0% 
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Comparing 24 hr urinary calcium among various Taq 1 genotypes: 
 
 
 
                              
 
 
 
 
Taq 1 genotype=TT
24 hr urinary calcium (mg/kg/day)
HypercalciuriaNormocalciuria
C
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u
n
t
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0
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Control
Cases
Taq 1 genotype=Tt
24 hr urinary calcium (mg/kg/day)
HypercalciuriaNormocalciuria
C
o
u
n
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2
0
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Control
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Taq 1 genotype=tt
24 hr urinary calcium (mg/kg/day)
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C
o
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0
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Analysis of Taq I genotype between the sexes 
 
Group     Sex Total P value 
    Male Female    
 
0.469 
Control Taq 1 
genotype 
TT Count 
14 17 31 
      % within Taq 
1 genotype 
45.2% 54.8% 100.0% 
      % within Sex 56.0% 68.0% 62.0%  
 
0.387 
 
    Tt Count 10 8 18 
      % within Taq 
1 genotype 
55.6% 44.4% 100.0% 
      % within Sex 40.0% 32.0% 36.0%  
 
 
0.290 
    tt Count 1 0 1 
      % within Taq 
1 genotype 
100.0% .0% 100.0% 
      % within Sex 4.0% .0% 2.0% 
  Total Count 25 25 50  
  % within Taq 
1 genotype 
50.0% 50.0% 100.0% 
 
  % within Sex 100.0% 100.0% 100.0%  
Cases Taq 1 
genotype 
TT Count 
9 6 15 
 
 
0.855       % within Taq 
1 genotype 
60.0% 40.0% 100.0% 
      % within Sex 31.0% 28.6% 30.0% 
    Tt Count 13 11 24  
 
0.855 
      % within Taq 
1 genotype 
54.2% 45.8% 100.0% 
      % within Sex 44.8% 52.4% 48.0% 
    tt Count 7 4 11  
 
0.899 
      % within Taq 
1 genotype 
63.6% 36.4% 100.0% 
      % within Sex 24.1% 19.0% 22.0% 
  Total Count 29 21 50  
  % within Taq 
1 genotype 
58.0% 42.0% 100.0% 
 
  % within Sex 100.0% 100.0% 100.0%  
 
 
 There was no statistically significant difference in the number of male 
and female cases and controls when comparing the incidence of various Taq I 
gene polymorphs. No sex predilection of a particular type of polymorph was 
noticed. 
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Comparing recurrent stone formers with sex 
 
 
Group     Sex Total P value 
    Male Female    
Cases Stone formers First Count 15 11 26  
 
0.963 
      % within Stone 
formers 
57.7% 42.3% 100.0% 
      % within Sex 51.7% 52.4% 52.0% 
    Recurrence Count 14 10 24  
 
0.963 
      % within Stone 
formers 
58.3% 41.7% 100.0% 
      % within Sex 48.3% 47.6% 48.0% 
  Total Count 29 21 50  
  % within Stone 
formers 
58.0% 42.0% 100.0% 
 
  % within Sex 100.0% 100.0% 100.0%  
 
Group=Cases
Taq 1 genotype
ttTtTT
C
o
u
n
t
14
12
10
8
6
4
2
Sex
Male
Female
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 Though the number of male stone formers with recurrent disease 
appears to be more(14/24) there was no statistically significant sex predilection 
towards recurrent stone formers. 
 
Comparing the family history of stone formers: 
 
 Family history was positive in 6 recurrent stone formers and 5 first time 
stone formers depicting the absence of any statistically significant association 
between family history and recurrence in our study. It’s unusual to see that the 
family history was positive in only 22% of stone forming cases(11 out of 50 
cases).           
 
Group=Cases
Stone formers
RecurrenceFirst
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Comparing the family history of stone formers: 
 
   Family history Total P value 
    Yes No    
Stone formers First Count 5 21 26  
 
0.623 
    % within Stone 
formers 
19.2% 80.8% 100.0% 
    % within Family 
history 
45.5% 53.8% 52.0% 
  Recurrence Count 6 18 24  
 
0.821 
    % within Stone 
formers 
25.0% 75.0% 100.0% 
    % within Family 
history 
54.5% 46.2% 48.0% 
Total Count 11 39 50  
  % within Stone 
formers 
22.0% 78.0% 100.0% 
 
  % within Family 
history 
100.0% 100.0% 100.0% 
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Correlating Taq I genotypes with family history: 
 
 
Family 
history     Sex Total 
P value 
    Male Female    
Yes Taq 1 
genotype 
TT Count 
0 1 1 
 
 
0.370       % within Taq 
1 genotype 
.0% 100.0% 100.0% 
      % within Sex .0% 25.0% 9.1% 
    Tt Count 2 1 3  
 
0.329 
      % within Taq 
1 genotype 
66.7% 33.3% 100.0% 
      % within Sex 28.6% 25.0% 27.3% 
    tt Count 5 2 7  
 
0.281 
      % within Taq 
1 genotype 
71.4% 28.6% 100.0% 
      % within Sex 71.4% 50.0% 63.6% 
  Total Count 7 4 11 
  % within Taq 
1 genotype 
63.6% 36.4% 100.0% 
 
  % within Sex 100.0% 100.0% 100.0%  
No Taq 1 
genotype 
TT Count 
9 5 14 
 
 
0.756       % within Taq 
1 genotype 
64.3% 35.7% 100.0% 
      % within Sex 40.9% 29.4% 35.9% 
    Tt Count 11 10 21  
 
0.754 
      % within Taq 
1 genotype 
52.4% 47.6% 100.0% 
      % within Sex 50.0% 58.8% 53.8% 
    tt Count 2 2 4  
 
 
0.491 
      % within Taq 
1 genotype 
50.0% 50.0% 100.0% 
      % within Sex 9.1% 11.8% 10.3% 
  Total Count 22 17 39 
  % within Taq 
1 genotype 
56.4% 43.6% 100.0% 
  % within Sex 100.0% 100.0% 100.0%  
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 Family history was not statistically significant between the three types 
of polymorphs. Numerically tt polymorphs had the highest number of positive 
family history(7 out of 11 cases) contributing 63.6 % to the group. Though this 
value appears to be high, pointing a correlation between tt genotype and family 
history , is not statistically significant. 
 
 Most of family history positive cases are males belonging to both tt and 
Tt genotypes once again giving an idea that the “t” allele may have a positive 
role in family history.   
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Comparing Taq 1 genotypes with stone formers: 
 
Sex     Stone formers Total P value 
    First Recurrence    
Male Taq 1 
genotype 
TT Count 
6 3 9 
 
 
0.073       % within Taq 1 
genotype 
66.7% 33.3% 100.0% 
      % within Stone 
formers 
40.0% 21.4% 31.0% 
    Tt Count 8 5 13  
 
0.059 
      % within Taq 1 
genotype 
61.5% 38.5% 100.0% 
      % within Stone 
formers 
53.3% 35.7% 44.8% 
    tt Count 1 6 7  
 
 0.049 
      % within Taq 1 
genotype 
14.3% 85.7% 100.0% 
      % within Stone 
formers 
6.7% 42.9% 24.1% 
  Total Count 15 14 29  
  % within Taq 1 
genotype 
51.7% 48.3% 100.0% 
 
  % within Stone 
formers 
100.0% 100.0% 100.0% 
 
Female Taq 1 
genotype 
TT Count 
3 3 6 
 
 
0.044       % within Taq 1 
genotype 
50.0% 50.0% 100.0% 
      % within Stone 
formers 
27.3% 30.0% 28.6% 
    Tt Count 8 3 11  
 
 
0.023 
      % within Taq 1 
genotype 
72.7% 27.3% 100.0% 
      % within Stone 
formers 
72.7% 30.0% 52.4% 
    tt Count 0 4 4  
 
 
0.022 
      % within Taq 1 
genotype 
.0% 100.0% 100.0% 
      % within Stone 
formers 
.0% 40.0% 19.0% 
  Total Count 11 10 21   
  % within Taq 1 
genotype 
52.4% 47.6% 100.0% 
 
  % within Stone 
formers 
100.0% 100.0% 100.0% 
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Stratifying Taq I genotype among male stone formers: 
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 The recurrence of stone disease among male population was high in tt 
genotype, with definitive statistically significant increase.Among female  cases 
recurrence of stone disease was statistically significant in Tt and tt  
polymorphs. Altogether tt genotype  is responsible for recurrence of stone 
formation. 
 
1. 91.7 % of tt genotypic individuals are stone formers. 
2. Presence of “t” allele increases the risk for stone formation statistically. 
3. The percentage  of stone disease is least in TT genotype. 
4. Hypercalciuria was seen in 75% of tt genotypes. Both ‘tt’ and ‘Tt’ 
genotypes have a statistically significant  increase in the incidence of 
hypercalciuria. 
5. No sex predilection was noticed for a particular phenotype. 
6. Though the number of male stone formers with recurrent disease are 
more(14/24) there is no statistical significance to it. 
7. Family history was positive in only 22 % of stone formers and no 
specific genotype was linked to this entity. 
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8. Numerically’ tt’ polymorphs had the highest number of positive family 
history(7 out of 11 cases) contributing 63.6 % to the group but the value 
is not statistically significant. 
9. ‘tt’ males had an increased chance of stone recurrence whereas Tt and tt 
females had an increased recurrence chance ,both proven statistically 
significant. 
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DISCUSSION 
 
 The present study investigated polymorphism in Vitamin D receptor 
gene Taq I and the risk of calcium nephrolithiasis in South Indian population. 
There are no studies from South India on this research till date.There are 
studies published from North India and these  studies  invoived only one 
Vitamin D receptor polymorphism Fok-I(H.K.Bid et al). Thus this the only 
Indian study looking for the role of  Taq I gene polymorphism in calcium 
urolithiasis. 
The results of present study were compared with a systemic meta analysis 
 
 
(1) ‘NS’ – Unspecified stone composition , while ‘Calcium’ indicates calcium stone. ‘N’ 
indicates the genotype distribution of the corresponding control group deviated from HWE, 
‘Y’ indicates the consistence with HWE. (2) HWE. Hardy Weinburgh Equilibirium) 
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 Calcium mineral metabolism is altered by altered vitamin D receptor 
gene polymorphisms. There are so many studies to prove the association of 
this gene with osteoporosis, prostatic carcinoma, Psoriasis and urolithiasis. 
Basically the polymorphism in the untranslated region of  VDR gene ie. TaqI, 
BsmI and ApaI don’t actually change the amino acid sequence. Anyhow the 
hypothesized mechanism of  stone formation  is due to alteration in mRNA 
stability or a change in vitamin D activity.But these presumptions are not 
scientifically proven till date. 
 
 There are various studies conducted world over for and against VDR 
polymorphism in gene formation. Nothing is conclusive among published 
results and no association of genetic polymorphism is actually supported. 
 
 In previous studies, Jackman et al.  in 1999 showed the association 
between ‘TT’ genotype and stone formation in western population. This is 
completely contrary to what we have noticed in our study. In our study ‘TT’ 
genotype has the least risk of stone formation . 
 
 But the study done by Nishijima et al in a group of Japanese Asian 
population showed a clear link between ‘tt’ genotype and stone formation.  
 
 The work done by Serkan Seyhan et al in Turkish children has results 
similar to our study which links the presence of ‘t’ allele to recurrent stone 
formation. But this Turkish study links the presence of ‘t’ allele to positive 
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family history which was not observed in our study. The educational status and 
intelligent quotient of the patient including his socioeconomic back ground has 
a strong influence in getting a proper history from a patient. That may be the 
reason why the percentage of cases with positive family history is too low in 
our setup owing to many of family history being missed because of patient’s 
unawareness.This Turkish study also had a significant correlation with 
hypercalciuria especially in cases with Tt,tt genotypes which is similar to our 
report. 
 
 In other studies especially the one by Mosetti et al, they took 
hypocitraturia as a parameter and found that genetics polymorphs had a 
correlation with this parameter especially in recurrent stone disease. We didn’t 
take urinary  citrate as one of our parameters. 
 
 Ozkaya et al tested for polymorphism in other regions  of VDR gene 
like Apa I.Bsm I including Taq I and found that AA polymorphs of Apa I had 
significantly more hypercalciuric urolithiasis.In contrary to our observation he 
found that there is no association with Taq I polymorphism and urolithiasis. 
 
 They also showed that the  ‘TT’ genotype is significantly associated 
with a positive family history. 
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 Another study by, Gunes et al. found no correlation between stone risk 
and the three mentioned polymorphisms. The only finding noticed was Apa I 
polymorphism and positive family history. 
 
 The reason for such gross alterations in results was due to other factors 
like environmental factors, ethnicity and due to technical differences in 
different laboratories.  
 
The meta analysis done by Yiwei Lin et al tabulates the results as follows 
 
 
 The Odd’s ratio within 95% confidence intervals is found to be slightly 
more in both in allelic comparisons and  Dominant models. It’s interesting to 
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note that the Odd’s Ratio value is also slightly higher for Asian population just 
like our study, clearly stating that ethnicity has an important role in 
polymorphism and it’s effects. 
 
 The VDR gene regulates the following factors apart from Vitamin D: 
osteocalcine, parathyroid hormone,  calcitonine and various oncoproteins . As 
there are so many studies which correlate VDR gene polymorphism and 
prostatic cancer, parallel association studies between calcium urolithiasis and 
carcinoma prostate are almost not known in the literature.  
 
 VDR polymorphisms alters the mRNA transcription thereby being 
quoted in various other disorders.In a study the ‘T’ allele was found to 
decrease the chance of osteoporosis but paradoxically was associated with 
increased chance of osteoarthritis. Another  research paper on idiopathic 
hypercalciuria in children has observed idiopathic hypercalciuria to be found 
in association with severe osteopenia in the study group children.Idiopathic 
hypercalciuria-osteoporosis-calcium urolithiasis all are linked in several ways. 
 
 In conclusion, pathophysiology of urinary stone disease includes several 
previously described components, such as gender, ethnicity, environmental 
and dietary factors. Genetics is the only key to open this pandora’s box. As 
prevention is better than  cure these genetic studies aiming at detecting genetic 
markers are much more important. In future these studies will help human 
 
 
61 
 
community in prophylaxis against stone formation and identifying high risk 
individuals in preventing the recurrence of disease problem. 
 
 However, this study is just a beginning of a long journey and further 
studies planned in large scale with huge sample with various other risk factors 
comparing different races is required in the future. Our study is just a piece of 
evidence in analyzing the genetics of calcium stone disease, thereby forming a 
block of an unsolved puzzle. 
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CONCLUSIONS 
 
 The presence of “t” allele increases the risk for stone formation 
statistically. 
 Both tt and Tt genotypes have a statistically significant  increase in 
the incidence of hypercalciuria. 
 No specific genotype has a statistically significant association with a 
positive  family history. 
 ‘tt’ males had an increased chance of stone recurrence whereas ‘Tt’ 
and ‘tt’ females had an increased recurrence statistically.                                     
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PROFORMA 
 
ROLE OF VITAMIN D RECEPTOR GENE Taq 1  POLYMORPHISM 
IN RECURRENT UROLITHASIS 
 
Patient’s name   : ........................................................ 
Age/sex    : ........................................................ 
IP NO:    : ........................................................ 
Contact address   : ........................................................ 
     ........................................................ 
     ........................................................ 
Contact number   : ........................................................ 
 
Family History of Stone disease :  ........................................................ 
 
Type of Stone    :  ........................................................ 
 
First time (or) recurrent   :  ........................................................ 
stone former 
 
24 Hr. Urinary Calcium  :  ........................................................ 
 
Serum Calcium   : ........................................................ 
 
Serum Phosphorus   :  ........................................................ 
 
Serum 1,25 (OH)2 D3 Level :  ........................................................ 
 
Taq 1 Genotype   :  ........................................................ 
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